300
Participants
Start Date
December 6, 2017
Primary Completion Date
July 23, 2019
Study Completion Date
February 1, 2020
Tenecteplase
Tenecteplase 0.25mg/kg and 0.4mg/kg are being used
Auckland Hospital, Grafton
Royal Prince Alfred Hospital, Camperdown
Westmead Hospital, Westmead
Liverpool Hospital, Liverpool
Bankstown-Lidcombe Hospital, Bankstown
Gosford Hospital, Gosford
Campbelltown Hospital, Campbelltown
Royal North Shore Hospital, St Leonards
Albury Hospital, Albury
Alfred Hospital, Melbourne
Western Heath, St Albans
Royal Melbourne Hospital, Melbourne
Box Hill Hospital, Box Hill
Monash Medical Centre, Clayton
South West Healthcare, Warrnambool
Ballarat Health Services, Ballarat
Goulburn Valley Health, Shepparton
North East Health Wangaratta, Wangaratta
Latrobe Regional Hospital, Traralgon
Princess Alexandra Hospital, Woolloongabba
Sunshine Coast University Hospital, Nambour
Royal Adelaide Hospital, Adelaide
Lyell McEwin Hospital, Elizabeth Vale
Christchurch Hospital, Christchurch
John Hunter Hospital, Newcastle
Royal Brisbane & Women's Hospital, Brisbane
Gold Coast University Hospital, Gold Coast
Austin Hospital, Heidelberg
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
OTHER
Neuroscience Trials Australia
OTHER